Q98408074

Summary

Q98408074 is a report^[1].

Key Facts

• Q98408074's instance of is recorded as report^[2].
• Q98408074's part of the series is recorded as reports of the 2017/18 legislative session of the Riksdag^[3].
• Q98408074's language of work or name is recorded as Swedish^[4].
• Q98408074 was released on +2018-04-27T00:00:00Z^[5].
• Q98408074's significant event is recorded as debate^[6].
• Q98408074's main subject is medication^[7].
• Q98408074's work available at URL is recorded as http://data.riksdagen.se/dokument/H501SoU16^[8].
• Q98408074's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H501SoU16^[9].
• Q98408074's work available at URL is recorded as http://data.riksdagen.se/fil/509AB30A-22D2-4DB2-8449-2780145C1DF0^[10].
• Q98408074's applies to jurisdiction is recorded as Sweden^[11].
• Q98408074's legal citation of this text is recorded as bet. 2017/18:SoU16^[12].
• Q98408074's title is recorded as Apoteks- och läkemedelsfrågor^[13].
• Q98408074's has immediate cause is recorded as Q97755664^[14].
• Q98408074's has immediate cause is recorded as Q97726192^[15].
• Q98408074's has immediate cause is recorded as Q97724081^[16].
• Q98408074's has immediate cause is recorded as Q97722954^[17].
• Q98408074's has immediate cause is recorded as Q97724737^[18].
• Q98408074's has immediate cause is recorded as Q97726810^[19].
• Q98408074's has immediate cause is recorded as Q97754925^[20].
• Q98408074's has immediate cause is recorded as Q97722958^[21].
• Q98408074's has immediate cause is recorded as Q97724284^[22].
• Q98408074's has immediate cause is recorded as Q97735161^[23].
• Q98408074's has immediate cause is recorded as Q97726456^[24].
• Q98408074's has immediate cause is recorded as Q97760121^[25].
• Q98408074's has immediate cause is recorded as Q97723895^[26].

Body

Definition and Type

Q98408074's instance of is recorded as report^[2].